Posts by: Margarida Azevedo

Margarida Azevedo

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

July 25, 2016

Review Details Common Cellular, Immunological, Treatment Traits of Psoriasis, Inflammatory Bowel Disease

News

Psoriasis and inflammatory bowel disease (IBD), both chronic and inflammatory diseases, coexist in many patients and share genetic profiles. In a recent review, researchers explores and described the existing evidence ... Read more

July 21, 2016

Psoriasis Drug Siliq Supported by FDA Panel Despite Suicide Concerns

News

The U.S. FDA’s Dermatologic and Ophthalmic Drugs Advisory Committee voted unanimously for the approval of Valeant Pharmaceuticals’ Siliq (brodalumab). The full FDA is expected to make a decision on approval of the ... Read more

July 20, 2016July 20, 2016

Psoriasis: Symptom Severity, Quality of Life Sometimes Go Hand in Hand

News

Psoriasis is a dermatological disease that deeply impacts patients, not only physically but also emotionally when it comes to body image, self-esteem and overall quality of life. Researchers at the Medical University ... Read more

July 7, 2016July 7, 2016

TNF Inhibitors Seen to Lower Cardiovascular Disease Risk in Psoriasis Patients

News

TNF inhibitors are commonly used to treat psoriasis and psoriatic arthritis patients, who are also at high risk of cardiovascular disease. Researchers investigated whether these drugs play a role in elevating that ... Read more

June 22, 2016

Psoriasis Patients Show Higher Presence of Metabolic Syndrome, Study Says

News

Researchers at the Medical University of Lodz accessed the prevalence of metabolic syndrome characteristics in patients with psoriasis, and how such abnormalities affect the disease activity. The findings suggest higher ... Read more

June 21, 2016

Survey of Patients with Psoriasis, Other Diseases, Identifies Knowledge Gaps About Biosimilars

News

Researchers at Pfizer conducted a survey on the knowledge, awareness, and usage of biosimilars among caregivers, patients — including psoriasis patients — and the general population in the U.S. and ... Read more

June 20, 2016

Serious Infections More Prevalent in Inpatients with Psoriasis, Related to Higher Costs and Longer Hospital Stays

News

Researchers at Northwestern University’s Feinberg School of Medicine investigated the rates and predictors of serious infections in hospitalized patients with psoriasis and also quantified the costs of their care, length ... Read more

June 16, 2016

Can-Fite to Report New Data on Piclidenoson, a Biologic to Treat Psoriasis, at Paris Congress

News

Can-Fite BioPharma, Ltd., announced that its lead drug candidate, Piclidenoson (CF101), has shown similar anti-inflammatory efficacy to the biologics currently on the market for the treatment of psoriasis, with the ... Read more

June 15, 2016

Life Course Approach May Improve Understanding, Management of Psoriasis, Other Chronic Skin Diseases

News

A multi-disciplinary team of researchers conducted a study with the goal of raising the profile of the life course approach, a sociology research tool used in increasing popularity in health research ... Read more

June 9, 2016

Researchers Find Potential Psoriasis Therapeutic Target in B-Cells and Their Role in Inflammation

News

Researchers focused on B-cells and their possible role in the inflammation characteristic of psoriasis and identified a protein that may constitute a potential therapeutic target to treat the disease. The ... Read more